-transparent.png){kind=logo}
Recombinant vaccinia virus expressing the middle hepatitis B virus surface antigen was incapable of inducing marked antibody response against the S and pre-S2 antigenic specifities in mice. However, mice immunized with this virus produced antibodies to both these antigens after the following administration of subtreshold doses of plasmatic hepatitis B surface antigen.
Related Publications
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
June 1993,
Immunology letters,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
February 1989,
Vaccine,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
September 1991,
Biochemical and biophysical research communications,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
April 1983,
Nature,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
January 1989,
Chinese journal of biotechnology,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
October 1990,
Molekuliarnaia genetika, mikrobiologiia i virusologiia,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
January 2006,
Human vaccines,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
January 1985,
Doklady Akademii nauk SSSR,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
September 1981,
Proceedings of the National Academy of Sciences of the United States of America,
E Hamsíková, and
H Závadová, and
L Kutinová, and
V Ludvíková, and
V Krchnák, and
S Némecková, and
V Vonka
March 1987,
Vaccine,
